Excellent. I look forward to our return to the $15’s.
- Forums
- ASX - By Stock
- NEU
- Ann: Phase 2 trial shows significant improvements in Angelman
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.46%
!
$12.90

Ann: Phase 2 trial shows significant improvements in Angelman, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.90 |
Change
-0.060(0.46%) |
Mkt cap ! $1.612B |
Open | High | Low | Value | Volume |
$12.82 | $13.02 | $12.70 | $823.2K | 64.12K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 162 | $12.89 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.90 | 17 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 135 | 12.890 |
4 | 269 | 12.880 |
5 | 532 | 12.870 |
4 | 706 | 12.860 |
4 | 1243 | 12.850 |
Price($) | Vol. | No. |
---|---|---|
12.910 | 287 | 8 |
12.920 | 722 | 8 |
12.930 | 1482 | 9 |
12.940 | 1433 | 7 |
12.950 | 1214 | 6 |
Last trade - 10.41am 17/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online